Lupin Limited - Company Snapshot & SWOT Analysis
The business segments of Lupin mainly comprise of APIs and Formulations, and the company manufactures and markets pharmaceutical products in all major markets across the globe. The company is the tenth largest pharmaceutical company in the world by sales. In the domestic market, Lupin has a presence in key growth therapies such as Cardiology, Central Nervous System, Diabetology, Respiratory, Gynecology, Anti-Infective, Gastro-Intestinal, and Oncology. Not unusual for a key player in India, Lupin employs market segmentation strategy along medical specialty lines to drive growth.
During the period of 2014-2018, the company increased its revenue from INR 111.7 bn to INR 155.60 bn, registering an average growth rate of 8.64%. In 2018 the revenue declined because of various reasons like challenges faced by US business concomitant to adverse competitive dynamics as well as regulatory hurdles limiting new launches to offset the impact.
Scope of the Lupin Limited - Company Snapshot & SWOT Analysis Report
During the period of 2014-2018, the company increased its revenue from INR 111.7 bn to INR 155.60 bn, registering an average growth rate of 8.64%. In 2018 the revenue declined because of various reasons like challenges faced by US business concomitant to adverse competitive dynamics as well as regulatory hurdles limiting new launches to offset the impact.
Scope of the Lupin Limited - Company Snapshot & SWOT Analysis Report
- This report provides detailed information about Lupin Limited including value chain analysis, financial performance, business strategy and SWOT analysis.
- The report identifies the growth drivers and inhibitors for global pharmaceutical market.
- This report provides information about current and future trends for global pharmaceutical market.
1. EXECUTIVE SUMMARY
Scope of the Lupin Limited - Company Snapshot & SWOT Analysis Report
Research Methodology
2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET
3. COMPANY PROFILE
3.1 Lupin Limited
3.1.1 Company Profile
3.1.2 Lupin Limited in Pharma Manufacturing Value Chain
3.1.3 Lupin Limited: Financial Performance
3.1.4 Lupin Limited: Business Strategy
11.6.4.1 Product Level Strategy
3.1.5 SWOT Analysis of Lupin Limited
Strengths
Weaknesses
Opportunities
Threats
4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET
Orphan Drugs
Biologics and Biosimilars
Current Trends
1. INCREASING SEVERITY OF DRUG PRICE CONTROLS
2. GREATER FOCUS ON RARE DISEASES / ORPHAN DRUGS
3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS
4. INCREASING FOCUS ON CELL THERAPY
5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM
6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS
7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY
Notes
Company Information
Scope of the Lupin Limited - Company Snapshot & SWOT Analysis Report
Research Methodology
2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET
3. COMPANY PROFILE
3.1 Lupin Limited
3.1.1 Company Profile
3.1.2 Lupin Limited in Pharma Manufacturing Value Chain
3.1.3 Lupin Limited: Financial Performance
3.1.4 Lupin Limited: Business Strategy
11.6.4.1 Product Level Strategy
3.1.5 SWOT Analysis of Lupin Limited
Strengths
Weaknesses
Opportunities
Threats
4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET
Orphan Drugs
Biologics and Biosimilars
Current Trends
1. INCREASING SEVERITY OF DRUG PRICE CONTROLS
2. GREATER FOCUS ON RARE DISEASES / ORPHAN DRUGS
3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS
4. INCREASING FOCUS ON CELL THERAPY
5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM
6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS
7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY
Notes
Company Information
LIST OF EXHIBITS
Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key Information of Lupin Limited
Exhibit 3.2 Contact Information of Lupin Limited
Exhibit 3.3 Lupin Limited in Pharma Manufacturing Value Chain
Exhibit 3.4 Lupin Limited Sales 2014-2018 (in INR billion)
Exhibit 3.5 Year-wise Lupin Limited Sales Growth 2014-18 (in %)
Exhibit 3.6 Lupin Limited India Market Sales 20104-2018 (in INR billion)
Exhibit 3.7 Year-wise Lupin Limited Domestic Sales Growth 2015-2018 (in %)
Exhibit 3.8 Lupin Limited Export Sales 2010-2014 (in INR billion)
Exhibit 3.9 Year-wise Lupin Limited US Market Sales Growth 2017-2018 (in %)
Exhibit 3.10 Lupin Ltd. Rest of World (RoW) Sales (in INR bn)
Exhibit 3.11 Year wise Lupin Ltd. Rest of World Sales Growth (in %)
Exhibit 3.12 Country wise Revenue share of Lupin Ltd. (in %)
Exhibit 3.13 Country wise Revenue CAGR Growth Forecast for Lupin Ltd. 2019-23 (in %)
Exhibit 3.14 Forecast of Lupin Ltd. 2019-23 (in INR bn)
Exhibit 3.15 Growth Forecast of India Market for Lupin Ltd. Market 2019-23 (in INR bn)
Exhibit 11.83 Growth Forecast of US market for Lupin Ltd. 2019-23 (in INR bn)
Exhibit 3.17 Growth Forecast of rest of world for Lupin Ltd. 2019-23 (in INR bn)
Exhibit 3.18 Key Products of Lupin Limited
Exhibit 3.19 SWOT Analysis of Lupin Limited
Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key Information of Lupin Limited
Exhibit 3.2 Contact Information of Lupin Limited
Exhibit 3.3 Lupin Limited in Pharma Manufacturing Value Chain
Exhibit 3.4 Lupin Limited Sales 2014-2018 (in INR billion)
Exhibit 3.5 Year-wise Lupin Limited Sales Growth 2014-18 (in %)
Exhibit 3.6 Lupin Limited India Market Sales 20104-2018 (in INR billion)
Exhibit 3.7 Year-wise Lupin Limited Domestic Sales Growth 2015-2018 (in %)
Exhibit 3.8 Lupin Limited Export Sales 2010-2014 (in INR billion)
Exhibit 3.9 Year-wise Lupin Limited US Market Sales Growth 2017-2018 (in %)
Exhibit 3.10 Lupin Ltd. Rest of World (RoW) Sales (in INR bn)
Exhibit 3.11 Year wise Lupin Ltd. Rest of World Sales Growth (in %)
Exhibit 3.12 Country wise Revenue share of Lupin Ltd. (in %)
Exhibit 3.13 Country wise Revenue CAGR Growth Forecast for Lupin Ltd. 2019-23 (in %)
Exhibit 3.14 Forecast of Lupin Ltd. 2019-23 (in INR bn)
Exhibit 3.15 Growth Forecast of India Market for Lupin Ltd. Market 2019-23 (in INR bn)
Exhibit 11.83 Growth Forecast of US market for Lupin Ltd. 2019-23 (in INR bn)
Exhibit 3.17 Growth Forecast of rest of world for Lupin Ltd. 2019-23 (in INR bn)
Exhibit 3.18 Key Products of Lupin Limited
Exhibit 3.19 SWOT Analysis of Lupin Limited
